ACM
SEEL

Aquatic Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Aquatic Capital Management’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 1633
2022
Q2 		– Sell
-2
Closed -$5.21K – 1645
2022
Q1 		$5K Buy
+2
New +$8.6K 0.01% 843

Other funds holding SEEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Aquatic Capital Management's SEEL Position: Q3 2022 in Review

Aquatic Capital Management held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Aquatic Capital Management first reported a position in SEEL in Q1 2022 and has held it in 1 quarter since. The position peaked at $5K in Q1 2022. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.

  • Aquatic Capital Management held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q3 2022.
  • Aquatic Capital Management left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q3 2022.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of Aquatic Capital Management's portfolio in Q3 2022, its #1633 holding.
  • Aquatic Capital Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2022 and has held it in 1 quarter since.
  • Aquatic Capital Management's Seelos Therapeutics, Inc. Common Stock position peaked at $5K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.